Colgate (NYSE: CL) HR chief nets stock award, tax share sale

Rhea-AI Filing Summary

Colgate-Palmolive Chief Human Resources Officer Sally Massey reported stock-based compensation activity tied to performance awards. She acquired 16,805 shares of Common Stock at no cost from the vesting of previously granted performance-based restricted stock units earned under the company’s incentive plan. To cover tax obligations from this vesting, 8,206 shares were disposed of through a tax-withholding transaction at $97.10 per share, rather than an open-market sale. After these transactions, she directly owns 22,384 shares of Common Stock and indirectly holds 8,111 shares through the issuer’s 401(k) plan trustee.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Massey Sally

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/23/2026		A(1)		16,805	A	$0.0000	30,590	D
Common Stock	02/23/2026		F(2)		8,206	D	$97.1	22,384	D
Common Stock								8,111	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents vesting of a previously-granted performance-based restricted stock unit ("PBRSU") that was earned under the issuer's incentive compensation plan based on the achievement of performance goals for a completed performance period. The earned PBRSUs are settled solely in shares of Common Stock.

2. Withholding of shares for payment of tax liability incident to the vesting of PBRSUs under the issuer's incentive compensation plan.

	/s/ Kristine Hutchinson, Attorney-in-Fact	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Colgate-Palmolive (CL) report for Sally Massey?

Colgate-Palmolive reported that Chief Human Resources Officer Sally Massey had performance-based restricted stock units vest into 16,805 Common Stock shares. These shares were earned under the company’s incentive compensation plan after achieving specified performance goals over a completed performance period.

How many Colgate-Palmolive (CL) shares were used to cover taxes for the award?

To satisfy tax withholding related to the vesting of performance-based restricted stock units, 8,206 Colgate-Palmolive Common Stock shares were disposed of at $97.10 per share. This was a tax-withholding disposition, not an open-market sale initiated for portfolio or valuation reasons.

How many Colgate-Palmolive (CL) shares does Sally Massey own after the Form 4?

After the reported transactions, Sally Massey directly owns 22,384 shares of Colgate-Palmolive Common Stock. She also has indirect ownership of 8,111 shares held by the issuer’s 401(k) plan trustee, reflecting retirement-plan holdings in addition to her directly held shares.

What is the nature of the stock award reported for Colgate-Palmolive (CL)?

The award reflects vesting of previously granted performance-based restricted stock units that were earned under Colgate-Palmolive’s incentive compensation plan. Vesting occurred after achievement of defined performance goals, and the earned PBRSUs were settled solely in shares of Common Stock rather than cash.

Was the Colgate-Palmolive (CL) insider transaction an open-market buy or sell?

The Form 4 does not report an open-market buy or sell. It shows a grant-sized acquisition from vesting of 16,805 performance-based restricted stock units and a 8,206-share tax-withholding disposition to cover liabilities arising from that vesting event.